These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17520744)

  • 1. Central nervous system juvenile xanthogranuloma with malignant transformation.
    Orsey A; Paessler M; Lange BJ; Nichols KE
    Pediatr Blood Cancer; 2008 Apr; 50(4):927-30. PubMed ID: 17520744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary central nervous system histiocytic sarcoma.
    Laviv Y; Zagzag D; Fichman-Horn S; Michowitz S
    Brain Tumor Pathol; 2013 Jul; 30(3):192-5. PubMed ID: 23135612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary juvenile xanthogranuloma mimicking intracranial tumor in children.
    Tamir I; Davir R; Fellig Y; Weintraub M; Constantini S; Spektor S
    J Clin Neurosci; 2013 Jan; 20(1):183-8. PubMed ID: 22999559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic juvenile xanthogranuloma with multiple central nervous system lesions.
    Meshkini A; Shahzadi S; Zali A; Tajeddini A; Mirzayan J; Hamdi A
    J Cancer Res Ther; 2012; 8(2):311-3. PubMed ID: 22842385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile xanthogranuloma: forms of systemic disease and their clinical implications.
    Freyer DR; Kennedy R; Bostrom BC; Kohut G; Dehner LP
    J Pediatr; 1996 Aug; 129(2):227-37. PubMed ID: 8765620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Extracutaneous Juvenile Xanthogranuloma With Multiple Intracranial Nodular Lesions Successfully Treated With 2-Chlorodeoxyadenosine.
    Matsukawa Y; Sakamoto K; Shioda Y
    J Pediatr Hematol Oncol; 2022 Apr; 44(3):e823-e825. PubMed ID: 34486561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlipidized juvenile xanthogranuloma: an unusual variant with a potential diagnostic pitfall.
    Batista AC; Mendonça EF; Arantes Elias LS; Andrade BA; Almeida OP; León JE
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):295-9. PubMed ID: 22204961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cutaneous "histiocytoses".
    Zelger B; Burgdorf WH
    Adv Dermatol; 2001; 17():77-114. PubMed ID: 11758126
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine.
    Rajendra B; Duncan A; Parslew R; Pizer BL
    Pediatr Blood Cancer; 2009 Mar; 52(3):413-5. PubMed ID: 18989881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal juvenile xanthogranuloma presenting as a sellar lesion: case report and literature review.
    Ferguson SD; Waguespack SG; Langford LA; Ater JL; McCutcheon IE
    Childs Nerv Syst; 2015 May; 31(5):777-84. PubMed ID: 25503249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterile brain abscess due to juvenile xanthogranuloma: DWI characteristics.
    Kwak ES; Marrero DE; Pfannl R; Erbay SH
    J Neuroimaging; 2013 Jul; 23(3):437-40. PubMed ID: 22788960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile xanthogranulomas of the nervous system: A report of two cases and review of the literature.
    Deisch JK; Patel R; Koral K; Cope-Yokoyama SD
    Neuropathology; 2013 Feb; 33(1):39-46. PubMed ID: 22640164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma.
    Techavichit P; Sosothikul D; Chaichana T; Teerapakpinyo C; Thorner PS; Shuangshoti S
    Hum Pathol; 2017 Nov; 69():118-122. PubMed ID: 28504206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile xanthogranuloma of the cauda equina.
    Castro-Gago M; Gómez-Lado C; Alvez F; Alonso A; Vieites B
    Pediatr Neurol; 2009 Feb; 40(2):123-5. PubMed ID: 19135628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocytic sarcoma of the central nervous system: a challenging diagnosis.
    Devic P; Androdias-Condemine G; Streichenberger N; Berger F; Honnorat J; Broussolle E; Thobois S
    QJM; 2012 Jan; 105(1):77-9. PubMed ID: 21186180
    [No Abstract]   [Full Text] [Related]  

  • 17. Subdural effusion in a CNS involvement of systemic juvenile xanthogranuloma: a case report treated with vinblastin.
    Auvin S; Cuvellier JC; Vinchon M; Defoort-Dhellemes S; Soto-Ares G; Nelken B; Vallée L
    Brain Dev; 2008 Feb; 30(2):164-8. PubMed ID: 17720345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. September 2000: 15 year old girl with intracranial lesion.
    Gutnik H; Dolenc-Strazar Z; Popovic M
    Brain Pathol; 2001 Jan; 11(1):123-5. PubMed ID: 11145200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.
    Iwabuchi H; Kawashima H; Umezu H; Takachi T; Imamura M; Saitoh A; Ogose A; Imai C
    Int J Hematol; 2017 Aug; 106(2):299-303. PubMed ID: 28247189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of juvenile xanthogranuloma.
    Stover DG; Alapati S; Regueira O; Turner C; Whitlock JA
    Pediatr Blood Cancer; 2008 Jul; 51(1):130-3. PubMed ID: 18338395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.